Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

MYND Life Sciences Provides Update On Depression Gene Modulation Pathway Patent Application

MYND Life Sciences Inc. is pleased to announce it has completed the National Phase filing of its Patent Cooperation Treaty (PCT) patent application, following on previously submitted provisional patent applications that describe:  “A Method of Immune Modulation by Modulating a Specific Gene.”

Recommended AI News : Predictions Series 2022: Interview with Param Kahlon, Chief Product Officer at UiPath

PREDICTIONS-SERIES-2022

“MYND’s is profoundly different than the majority of the Psychedelics’ sector. We are seeking intellectual property protection through the pursuit of patents by validation of our Intellectual Property through research and development,” stated Dr. Lyle Oberg, MD, CEO of MYND. “As this sector grows and matures and as MYND develops our novel drug development pipeline, the creation of a solid intellectual property portfolio is the key to creating lasting shareholder value. MYND’s ability to obtain patent protection will allow us to move towards the filing of Innovative New Drug (IND) application and approval status.”

According to the World Health Organization, over 300,000,000 people globally suffer from depression and other psychiatric disorders. Major Depressive Disorder and Treatment Resistant Depression have a greater than 50% chance of relapse using conventional methods of treatment. Traditional treatments focus solely on symptom suppression, not the root cause. Covid-19 has accelerated the ongoing mental health crisis around the world. In a June 2020 CDC survey, 31% of US respondents reported symptoms of anxiety or depression, 13% started/increased substance use, 26% reported stress-related symptoms, 11% reported serious thoughts of suicide in preceding 30 days. These numbers are double pre-pandemic levels.

Related Posts
1 of 40,433

Biggest Ads of 2021: Can You Guess The 2021’S Most Emotionally Engaging Holiday Ads In The APAC Region?

The Patent Cooperation Treaty (PCT) is an international treaty with more than 150 Contracting States. The PCT makes it possible to seek patent protection for an invention simultaneously in a large number of countries by filing a single “international” patent application instead of filing several separate national or regional patent applications.

MYND MARKETING AND INVESTOR RELATIONS AGREEMENTS

MYND has retained Hybrid Financial Ltd.  to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for MYND and to broaden it’s reach within the biotech drug research and development investment community. Hybrid has been engaged for a monthly fee of $22,500 by the Company for an initial period of twelve months, commencing November 16, 2021.

Recommended AI News: Mobilum Technologies Signs Agreement To Integrate Off-Ramp Services Into The Ledger Live Platform, Gateway For Digital Assets & Web3

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.